Wall Street Caves in to Anti-Science Terrorists

Forces who oppose scientific research scored a big victory when the New York Stock Exchange dropped its plans to list an animal-research firm, Life Sciences Research, on Sept. 7. To reward their abusive behavior is to reward senseless violence. We wouldn't let zealots do this to people who work in abortion clinics. We shouldn't let them do it to medical researchers.

Wall Street caves in to terrorists

The "Postive" Era of Gentically Modified Foods is Upon Us.

� Sugar beets that produce fructans, a sweet-tasting type of sugar that is indigestible � a plus in weight management.

� Soybeans containing low levels of linolenic acid, thereby eliminating the need for hydrogenation, a chemical process that increases soy oil's shelf-life but produces harmful trans-fatty acids.

� Soybeans and other oilseed crops with increased levels of beneficial fatty acids, such as canola, which contains high levels of stearic acid.

� White corn with higher levels of unsaturated fat.

� Sunflowers with oil low in saturated fat but higher in oleic acid content.

� Soybeans with increased sucrose content that taste better and are more easily digested.

� Vegetables that ripen more slowly, allowing more time to travel from field to market.


BioBOOM Op/Ed: Now they are getting it. Instead of genetics to just save money how about genetic modification to give us better health. This is what will turn the debate around. Although I would rather eat corn with a gene agains bore resistant than pesticide but hey thats just me.

China promotes new typing reagent for leukemia

China has developed its own typing reagent of hematopoietic stem cell, which could be used to cure leukemia, according to sources with the Chinese Academy of Military Medical Sciences.

China finds new cure for leukemia

BioBOOM Op/Ed: The funny part on this one is the actual headlines says China finds new cure of leukemia. Its simply another HLA-DRB1 typing reagent.

Which reminds us of a translation joke: A couple go for a meal at a Chinese restaurant and order the "Chicken Surprise". The waiter brings the meal served in a lidded cast iron pot. Just as the wife is about to serve herself, the lid of the pot rises slightly and she briefly sees two beady little eyes looking around before the lid slams back down. "Good grief, did you see that?" she asks her husband. He hadn't, so she asks him to look in the pot. He reaches for it and again the lid rises and he sees two little eyes looking around before it slams down. Rather perturbed he calls the waiter over, explains what is happening, and demands an explanation. "Please sir," says the waiter, "what you order?" The husband replies, "Chicken Surprise." "Ah. so sorry," says the waiter, "I bring you Peeking Duck"

New kind of health care is coming, says acting FDA chief

Now, doctors treat illnesses based on how well other people have responded to a given treatment. Soon, they will develop a tailored response built around specific understandings of the patient, the treatment and the disease, he said. "We are discovering so much about diseases like cancer at the molecular level," said von Eschenbach, a urologic surgeon. "Much of what we have done . . . has been based on a model of empiricism."

New kind of health care is coming, says acting FDA chief | The San Diego Union-Tribune: "Andrew von Eschenbach"

BioBOOM Op/Ed: This guy gets it! Too bad it's only "Acting" head of the FDA.

Possible Conflicts for Doctors Are Seen on Medical Devices

Many doctors have unusually close, if largely unseen, ties to device makers. And those relationships are a central issue on an emerging battleground in the health care wars: the upward cost spiral of implantable medical devices."

Possible Conflicts for Doctors Are Seen on Medical Devices - New York Times:

Thomas Tuschl's groundbreaking work in the field of RNA interference, 2005 Ernst Schering Prize awarded

Researchers have initial indications that certain diseases are connected to a disturbed microRNA pattern. Tuschl comments further: 'For example, the concentration of individual RNAs in the cells of certain tumors is noticeably high. This offers a completely new approach to fighting cancer.'

Thomas Tuschl's groundbreaking work in the field of RNA interference, 2005 Ernst Schering Prize awarded

BioBOOM Op/Ed: We think microRNA is the Today's biggest break through in medical research

Elan & Biogen plan relaunch of Tysabri

Shares in the two companies had plunged in February when they suspended sales of the drug after one MS patient died after using Tysabri with Biogen's Avonex drug. Elan and Biogen Idec say that they expect - within weeks - to submit additional safety information to US regulators in the hope of returning their drug Tysabri to the market as a treatment for multiple sclerosis.

RTE Business - Elan & Biogen plan relaunch of Tysabri

Gene that controls the severity of asthma identified

Yale School of Medicine researchers identified a gene prevalent in the population that controls the clinical severity of asthma, according to their report in this week's Proceedings of the National Academy of Sciences.

Gene that controls the severity of asthma identified

Study: Medical Research Spending Jumps

Total U.S. spending on medical research has doubled in the past decade to nearly $95 billion a year, though whether the money is being well spent needs much better scrutiny, a study has found. The imbalance between late-stage and early-stage research is growing, the authors wrote, and is due partly to lengthy clinical trials required for new drug approval and partly to pure marketing. Companies often run costly studies to show their drugs work better than competitors' drugs.

"Study: Medical Research Spending Jumps - Yahoo! News:

New Orleans' Health System Faces Crisis

This city's health care facilities have been shattered to an extent unmatched in U.S. history, and its hospital system faces grave challenges as residents begin returning, the vice president of the national hospital accreditation organization said Sunday. Cappiello expressed concern that some hospitals, desperate to get back into business for competitive as well as public-service reasons, might move too quickly, before all mold and contaminants from the flooding are removed. "I hope there's someone looking at all the health care assets and making sound decisions as the mayor faces overwhelming political pressure to let people back in," Cappiello said. "The federal government needs to go in there and make sure the hospitals are a safe environment before they're reopened."

New Orleans' Health System Faces Crisis - Yahoo! News

BioBOOM Op/Ed: We expect to see some earning drop for various suppliers who routinely shipped hospital supplies to the area, short term - then an increase.

Market forces block tailored medicines, says expert

According to a study, while drug companies have begun to develop genetic tests for experimental drugs, many of which have yet to go into clinical trials , common pharmaceuticals already widely prescribed by GPs and hospital doctors are largely being neglected. In Britain alone, an estimated 10,000 people die each year from the side effects of drugs, with tens of thousands more becoming seriously ill.

Guardian Unlimited | The Guardian | Market forces block tailored medicines, says expert

Scientists Find Genetic Clues in Fanconi Anemia

The discovery of two new genes that cause Fanconi anemia suggest the rare disease is linked to a DNA repair system that normally keeps people healthy, according to a new study. The new findings also add evidence to a link between Fanconi anemia and mutations in genes that increase a woman's risk of breast and ovarian cancers.

Scientists Find Clues in Fanconi Anemia - Yahoo! News

Glowing Mice - Jumping Genes

Glowing Mice This batch of eerily glowing mice may herald a new understanding of how genes work. Using a stretch of DNA taken from the cabbage looper moth, scientists at Yale have found a new way to insert genes into a mammal's genome. In this case, it's a glowing protein taken from coral. But the technology could be used to find new genes linked to cancer and perhaps even as a route to human gene therapy.

Glowing Mice From China And Other Oddities - Forbes.com

Exiled from their La. labs, scientists assess their losses

Hurricane Katrina devastated scientific research in this city, claiming thousands of laboratory animals, ruining valuable caches of tissue, and interrupting clinical experiments as patients scattered across the nation. Research into treatments for epilepsy, hypertension, and obesity, as well as the development of vaccines, has been severely impeded by the storm. Restoring what has been lost could easily take years, researchers said.

Exiled from their La. labs, scientists assess their losses - The Boston Globe

Calif.'s Stem Cell Agency Awards Grants

The recipients of the first 16 grants, totaling $39.7 million over three years, included multimillion dollar awards to Stanford University, the California Institute of Technology, the University of Southern California and eight campuses of the University of California. Three nonprofit research labs and the Children's Hospital of Los Angeles also received grants during the monthly meeting of the 29-member Independent Citizens' Oversight Committee, which runs the stem cell agency.

Calif.'s Stem Cell Agency Awards Grants - Yahoo! News

BioBOOM Op/Ed: Talk about some idiots. These yahoos at some far right of pluto group called Life Legal Defense Foundation is one of the reasons we are not moving on this research since they contine to use the courts against the vote (59% supported) simply holding up the voter APPROVED(yep 59%) money allocation. Hey LLDFer's this is not some religious theocracy we are living in. If you prefer that move to Iran

New Technique Tracks Stem Cells' Progress

Researchers found that the radioactive tracers outperformed the tracking ability of standard MRI, allowing the team to watch stem cells as they made their way to the heart and then subsequently to other organs such as the liver, kidneys and spleen


Study holds promise for new way to fight HIV

Researchers have confirmed for the first time the benefit of an innate defense system present in the few patients who remain healthy after years of infection with HIV despite receiving no treatment, according to an article published in the September edition of the Journal of Virology. The study found that the subset of HIV-infected patients referred to as long-term survivors or nonprogressors have higher amounts of a key enzyme in their white blood cells. At the same time, a related biotech company is poised to begin preclinical testing on a drug designed to confer similar protection on most HIV patients.

Study holds promise for new way to fight HIV

Breast Cancer Risk Increased for African Americans with Mitochondrial DNA Variant

African-American women who carry the 10398A mitochondrial DNA allele are 60 percent more likely to develop invasive breast cancer than African-American females without that genetic marker, according to research published in the September 1 issue of Cancer Research. In this study, the researchers focused on a specific variation (G10398A) in a mitochondrial gene called ND3, which serves as the blueprint for an important component of an enzyme called NADH dehydrogenase. In its changed state, however, an adenine is substituted for a guanine in the DNA structure, resulting in the enzyme containing the amino acid threonine instead of an alanine. The clinical implication of this seemingly trivial alteration is profound. Among the greater population of humans, carriers of 10398A appear to be at higher risk for Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis (Lou Gehrig’s disease), and other neurological disorders.

News | American Association for Cancer Research

Blog Archive